Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) shares fell 0.6% during mid-day trading on Tuesday . The company traded as low as $47.21 and last traded at $47.21. 203 shares were traded during mid-day trading, a decline of 72% from the average session volume of 717 shares. The stock had previously closed at $47.50.
Hikma Pharmaceuticals Price Performance
The stock’s 50-day simple moving average is $50.24 and its 200 day simple moving average is $50.15.
Hikma Pharmaceuticals Cuts Dividend
The business also recently declared a dividend, which was paid on Monday, September 30th. Shareholders of record on Tuesday, August 20th were paid a $0.62 dividend. The ex-dividend date was Monday, August 19th. This represents a yield of 2.98%. Hikma Pharmaceuticals’s dividend payout ratio is currently 10.34%.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Recommended Stories
- Five stocks we like better than Hikma Pharmaceuticals
- Investing in the High PE Growth Stocks
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- How to Invest in Small Cap Stocks
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- Stock Average Calculator
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
